Time-dependence of molecular mobility during structural relaxation and its impact on organic amorphous solids: An investigation based on a calorimetric approach

Pharmaceutical Research

Volumn 23, Issue 8, 2006, Pages 1906-1917

  Mao, Chen ^a   Chamarthy, Sai Prasanth ^a   Pinal, Rodolfo ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

Amorphous; Fictive temperature; Glass transition; Molecular mobility; Relaxation

Indexed keywords

INDOMETACIN; ORGANIC COMPOUND; SORBITOL; SUCROSE; TREHALOSE;

ARTICLE; CRYSTAL; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; ENTHALPY; ENTROPY; LIQUID; MATHEMATICAL MODEL; NONLINEAR SYSTEM; PHASE TRANSITION; PRIORITY JOURNAL; SOLID; STORAGE TEMPERATURE; TIME;

ALGORITHMS; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHYSICAL; CRYSTALLIZATION; INDOMETHACIN; NONLINEAR DYNAMICS; PHARMACEUTICAL PREPARATIONS; PHYSICOCHEMICAL PHENOMENA; SORBITOL; SUCROSE; TEMPERATURE; THERMODYNAMICS; TREHALOSE;

EID: 33746866413     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-006-9008-3     Document Type: Article

References (42)

1. Y. Aso, S. Yoshioka, and S. Kojima. Molecular mobility-based estimation of the crystallization rates of amorphous nifedipine and phenobarbital in poly(vinylpyrrolidone) solid dispersions. J. Pharm. Sci. 93:384-391 (2004).
2. V. Andronis, M. Yoshioka, and G. Zografi. Effects of sorbed water on the crystallization of indomethacin from the amorphous state. J. Pharm. Sci. 86:346-351 (1997).
3. Y. S. Guo, S. R. Bryn, and G. Zografi. Physical characteristics and chemical degradation of amorphous quinapril hydrochloride. J. Pharm. Sci. 89:128-143 (2000).
4. S. R. Byrn, W. Xu, and A. W. Newman. Chemical reactivity in solid-state pharmaceuticals: formulation implications. Adv. Drug Deliv. Rev. 48:115-136 (2001).
5. M. J. Pikal and S. Shah. The collapse temperature in freeze-drying - dependence on measurement methodology and rate of water removal from the glassy phase. J. Phys. Chem. 62:165-186 (1990).
6. K. Kawakami and M. J. Pikal. Calorimetric investigation of the structural relaxation of amorphous materials: evaluating validity of the methodologies. J. Pharm. Sci. 94:948-965 (2005).
7. B. C. Hancock and S. L. Shamblin. Molecular mobility of amorphous pharmaceuticals determined using differential scanning calorimetry. Thermochim. Acta 380:95-107 (2001).
8. J. S. Liu, D. R. Rigsbee, C. Stotz, and M. J. Pikal. Dynamics of pharmaceutical amorphous solids: the study of enthalpy relaxation by isothermal microcalorimetry. J. Pharm. Sci. 91:1853-1862 (2002).
9. K. Kawakami and Y. Ida. Direct observation of the enthalpy relaxation and the recovery processes of maltose-based amorphous formulation by isothermal microcalorimetry. Pharm. Res. 20:1430-1436 (2003).
10. S. P. Duddu, G. Z. Zhang, and P. R. DalMonte. The relationship between protein aggregation and molecular mobility below the glass transition temperature of lyophilized formulations containing a monoclonal antibody. Pharm. Res. 14:596-600 (1997).
11. V. Andronis and G. Zografi. The molecular mobility of supercooled amorphous indomethacin as a function of temperature and relative humidity. Pharm. Res. 15:835-842 (1998).
12. B. C. Hancock, S. L. Shamblin, and G. Zografi. Molecular mobility of amorphous pharmaceutical solids below their glass-transition temperatures. Pharm. Res. 12:799-806 (1995).
13. V. Andronis and G. Zografi. Molecular mobility of supercooled amorphous indomethacin, determined by dynamic mechanical analysis. Pharm. Res. 14:410-414 (1997).
14. S. Yoshioka, Y. Aso, S. Kojima, S. Sakurai, T. Fujiwara, and H. Akutsu. Molecular mobility of protein in lyophilized formulations linked to the molecular mobility of polymer excipients, as determined by high resolution C-13 solid-state NMR. Pharm. Res. 16:1621-1625 (1999).
15. S. Yoshioka, Y. Aso, and S. Kojima. Determination of molecular mobility of lyophilized bovine serum albumin and gamma-globulin by solid-state H-1 NMR and relation to aggregation-susceptibility. Pharm. Res. 13:926-930 (1996).
16. S. L. Shamblin, B. C. Hancock, Y. Dupuis, and M. J. Pikal. Interpretation of relaxation time constants for amorphous pharmaceutical systems. J. Pharm. Sci. 89:417-427 (2000).
17. G. Adam and J. H. Gibbs. On temperature dependence of cooperative relaxation properties in glass-forming liquids. J. Chem. Phys. 43:139-146 (1965).
18. A. Q. Tool and C. G. Eichlin. Variations caused in the heating curves of glass by heat treatment. J. Am. Ceram. Soc. 14:276-308 (1931).
19. I. M. Hodge. Enthalpy relaxation and recovery in amorphous materials. J. Non-Cryst. Solids 169:211-266 (1994).
20. G. W. Scherer. Use of the Adam-Gibbs equation in the analysis of structural relaxation. J. Am. Ceram. Soc. 67:504-511 (1984).
21. D. J. Plazek and J. H. Magill. Physical properties of aromatic hydrocarbons. I. Viscoelastic behavior of 1.3.5-tri-alpha-naphthyl benzene. J. Chem. Phys. 45:3038-3050 (1966).
22. M. A. Debolt, A. J. Easteal, P. B. Macedo, and C. T. Moynihan. Analysis of structural relaxation in glass using rate heating data. J. Am. Ceram. Soc. 59:16-21 (1976).
23. C. T. Moynihan, A. J. Easteal, J. Wilder, and J. Tucker. Dependence of glass-transition temperature on heating and cooling rate. J. Phys. Chem. 78:2673-2677 (1974).
24. B. C. Hancock, C. R. Dalton, M. J. Pikal, and S. L. Shamblin. A pragmatic test of a simple calorimetric method for determining the fragility of some amorphous pharmaceutical materials. Pharm. Res. 15:762-767 (1998).
25. R. Bohmer and C. A. Angell. Correlations of the nonexponentiality and state dependence of mechanical relaxations with bond connectivity in Ge-as-Se supercooled liquids. Phys. Rev. B 45:10091-10094 (1992).
26. R. Bohmer, K. L. Ngai, C. A. Angell, and D. J. Plazek. Nonexponential relaxations in strong and fragile glass formers. J. Chem. Phys. 99:4201-4209 (1993).
27. B. C. Hancock and G. Zografi. Characteristics and significance of the amorphous state in pharmaceutical systems. J. Pharm. Sci. 86:1-12 (1997).
28. K. J. Crowley and G. Zografi. The use of thermal methods for predicting glass-former fragility. Thermochim. Acta 380:79-93 (2001).
29. S. L. Shamblin, X. L. Tang, L. Q. Chang, B. C. Hancock, and M. J. Pikal. Characterization of the time scales of molecular motion in pharmaceutically important glasses. J. Phys. Chem. B 103:4113-4121 (1999).
30. S. L. Shamblin and G. Zografi. Enthalpy relaxation in binary amorphous mixtures containing sucrose. Pharm. Res. 15:1828-1834 (1998).
31. M. Goldstein. Viscous-liquids and glass-transition. 5. Sources of excess specific-heat of liquid. J. Chem. Phys. 64:4767-4774 (1976).
32. I. M. Hodge. Strong and fragile liquids-a brief critique. J. Non-Cryst. Solids 202:164-172 (1996).
33. Y. Aso, S. Yoshioka, and S. Kojima. Explanation of the crystallization rate of amorphous nifedipine and phenobarbital from their molecular mobility as measured by C-13 nuclear magnetic resonance relaxation time and the relaxation time obtained from the heating rate dependence of the glass transition temperature. J. Pharm. Sci. 90:798-806 (2001).
34. D. L. Zhou, G. G. Z. Zhang, D. Law, D. J. W. Grant, and E. A. Schmitt. Physical stability of amorphous pharmaceuticals: importance of configurational thermodynamic quantities and molecular mobility. J. Pharm. Sci. 91:1863-1872 (2002).
35. J. J. Li, Y. S. Guo, and G. Zografi. The solid-state stability of amorphous quinapril in the presence of beta-cyclodextrins. J. Pharm. Sci. 91:229-243 (2002).
36. T. Matsumoto and G. Zografi. Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinylacetate) in relation to indomethacin crystallization. Pharm. Res. 16:1722-1728 (1999).
37. X. M. Zeng, G. P. Martin, and C. Marriott. Effects of molecular weight of polyvinylpyrrolidone on the glass transition and crystallization of co-lyophilized sucrose. Int. J. Pharm. 218:63-73 (2001).
38. Y. Hu. Solid-state investigation of crystalline and amorphous lisinopril and stabilization of amorphous lisinopril and quinapril hydrochloride. Industrial and Physical Pharmacy, Ph. D., Purdue University, West Lafayette, 2001.
39. L. R. Hilden and K. R. Morris. Prediction of the relaxation behavior of amorphous pharmaceutical compounds. I. Master curves concept and practice. J. Pharm. Sci. 92:1464-1472 (2003).
40. V. K. Kakumanu and A. K. Bansal. Enthalpy relaxation studies of celecoxib amorphous mixtures. Pharm. Res. 19:1873-1878 (2002).
41. G. Williams. Molecular-motion in glass-forming systems. J. Non-Cryst. Solids 131:1-12 (1991).
42. R. Surana, A. Pyne, and R. Suryanarayanan. Effect of preparation method on physical properties of amorphous trehalose. Pharm. Res. 21:1167-1176 (2004).